The molecular diagnostics segment of Customized Therapeutics is engaged in the development of prognostic/predictive assays that enable personalized medicine to occur through pre-selection of patients based on individual genetic characteristics. We thus aid early risk assessment and determine safety and therapeutic efficacy profiles for each patient.
We acquire, validate and develop inventions that are in late research stage from National Labs, Universities and other Research Institutions, into clinically useful tests. These products are applicable to, and add value to the management of individuals undergoing treatment with potent and expensive therapies for these life threatening disorders.
Benefits of Using CTDx products:
* Ability to pre-select optimal therapeutics
* Clinically and Scientifically validated reliable assays
* Easy to use assay kits allow integration into any lab environment
* Quick turn-around time for test results